Abstract:Our findings provide an efficient combination strategy for increasing clinically important daptomycin production by enhancing aspartate precursor supply, abolishing by‐product red pigment production, engineering daptomycin biosynthetic gene cluster (BGC) by promoter replacement, and duplicating the engineered daptomycin BGC in Streptomyces roseosporus wild‐type strain. We finally obtained a maximal DAP titre of 350.7 μg/mL, representing the highest reported titre in shake‐flask fermentation. Such strategies can be readily applied in the overproduction of other antibiotics using aspartate as a precursor. Daptomycin (DAP), a novel cyclic lipopeptide antibiotic produced by Streptomyces roseosporus, is clinically important for treatment of infections caused by multidrug‐resistant Gram‐positive pathogens, but the low yield hampers its large‐scale industrial production. Here, we describe a combination metabolic engineering strategy for constructing a DAP high‐yielding strain. Initially, we enhanced aspartate (Asp) precursor supply in S. roseosporus wild‐type (WT) strain by separately inhibiting Asp degradation and competitive pathway genes using CRISPRi and overexpressing Asp synthetic pathway genes using strong promoter kasOp*. The resulting strains all showed increased DAP titre. Combined inhibition of acsA4, pta, pyrB, and pyrC increased DAP titre to 167.4 μg/mL (73.5% higher than WT value). Co‐overexpression of aspC, gdhA, ppc, and ecaA led to DAP titre 168 μg/mL (75.7% higher than WT value). Concurrently, we constructed a chassis strain favourable for DAP production by abolishing by‐product production (i.e., deleting a 21.1 kb region of the red pigment biosynthetic gene cluster (BGC)) and engineering the DAP BGC (i.e., replacing its native dptEp with kasOp*). Titre for the resulting chassis strain reached 185.8 μg/mL. Application of our Asp precursor supply strategies to the chassis strain further increased DAP titre to 302 μg/mL (2.1‐fold higher than WT value). Subsequently, we cloned the engineered DAP BGC and duplicated it in the chassis strain, leading to DAP titre 274.6 μg/mL. The above strategies, in combination, resulted in maximal DAP titre 350.7 μg/mL (2.6‐fold higher than WT value), representing the highest reported DAP titre in shake‐flask fermentation. These findings provide an efficient combination strategy for increasing DAP production and can also be readily applied in the overproduction of other Asp‐related antibiotics.

Direct Proteomic Mapping of Streptomyces Roseosporus NRRL 11379 with Precursor and Insights into Daptomycin Biosynthesis

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Direct proteomic mapping of Streptomyces Luteogriseus Strain 103 and cnn1 and insights into antibiotic biosynthesis.

Label‐free Proteomic Dissection on Dptp‐deletion Mutant Uncovers Dptp Involvement in Strain Growth and Daptomycin Tolerance of Streptomyces Roseosporus

A novel strategy of gene screen based on multi-omics in Streptomyces roseosporus

Daptomycin Antibiotic Production Processes in Fed-Batch Fermentation by Streptomyces Roseosporus NRRL11379 with Precursor Effect and Medium Optimization.

Metabolic Flux Analysis and Principal Nodes Identification for Daptomycin Production Improvement by Streptomyces Roseosporus

Transcriptional analysis of the effect of exogenous decanoic acid stress on Streptomyces roseosporus

Regulation of daptomycin biosynthesis in Streptomyces roseosporus: new insights from genomic analysis and synthetic biology to accelerate lipopeptide discovery and commercial production

Differential analysis of secondary metabolites by LC-MS following strain improvement of Streptomyces lydicus AS 4.2501.

Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin

Improvement of Daptomycin Production in Streptomyces Roseosporus Through the Acquisition of Pleuromutilin Resistance

UPLC-MS-Based Metabolomic Study Ofstreptomycesstrain HCCB10043 under Different Ph Conditions Reveals Important Pathways Affecting the Biosynthesis of A21978C Compounds

Manipulation of Kynurenine Pathway for Enhanced Daptomycin Production in Streptomyces Roseosporus

Strain Improvement of Streptomyces Roseosporus for Daptomycin Production by Rational Screening of He–Ne Laser and NTG Induced Mutants and Kinetic Modeling

Development of a native-locus dual reporter system for the efficient screening of the hyper-production of natural products in Streptomyces

Targeted Dereplication of Microbial Natural Products by High-Resolution Ms and Predicted Lc Retention Time

In silico aided metabolic engineering of Streptomyces roseosporus for daptomycin yield improvement

Antibacterial Mechanism of Daptomycin Antibiotic Against Staphylococcus Aureus Based on a Quantitative Bacterial Proteome Analysis.

Improving the Yield and Quality of Daptomycin in Streptomyces Roseosporus by Multilevel Metabolic Engineering

DepR1, a TetR Family Transcriptional Regulator, Positively Regulates Daptomycin Production in an Industrial Producer, Streptomyces Roseosporus SW0702